pilocarpine has been researched along with Adenocarcinoma, Basal Cell in 4 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auttara-Atthakorn, A | 1 |
| Sungmala, J | 1 |
| Anothaisintawee, T | 1 |
| Reutrakul, S | 1 |
| Sriphrapradang, C | 1 |
| Hidalgo Grau, LA | 1 |
| Opisso Juliá, LL | 1 |
| Roqué Meseguer, A | 1 |
| Yuste Graupera, M | 1 |
| Suñol Sala, X | 1 |
| Mourad, JJ | 1 |
| des Guetz, G | 1 |
| Debbabi, H | 1 |
| Levy, BI | 1 |
| Scherer, NM | 1 |
| Nathanson, NM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Exploratory Study. Endothelial Function and Vascular Biomarkers: Predictive Indicators of the Progression From Gestational Hypertension to Preeclampsia?[NCT04520048] | 110 participants (Anticipated) | Interventional | 2023-08-24 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pilocarpine and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials.
Topics: Adenocarcinoma; Amifostine; Bethanechol; Humans; Iodine Radioisotopes; Pilocarpine; Randomized Contr | 2022 |
3 other studies available for pilocarpine and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
[Postoperative unilateral acute glaucoma after abdominal surgery].
Topics: Acetazolamide; Acute Disease; Adenocarcinoma; Adrenergic beta-Antagonists; Aged, 80 and over; Colect | 2012 |
Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation.
Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2008 |
Differential regulation by agonist and phorbol ester of cloned m1 and m2 muscarinic acetylcholine receptors in mouse Y1 adrenal cells and in Y1 cells deficient in cAMP-dependent protein kinase.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Colforsin; Concanavalin A; Cyclic AMP; Endocytosis | 1990 |